← Leaderboards
Christopher F Rowley
Harvard University (Sch Of Public Hlth)
$2,047,803
Attributed
$2,047,803
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $320.1K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,047,803 · 3
By mechanism
R01$1,248,993 · 1
K08$542,025 · 1
R56$256,785 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Sch Of Public Hlth)
Same institution · by research overlap
- Myron E Essex$98,230,915
- Marc J Lallemant$19,725,823
- Eduardo Villamor$3,856,087
- Roger L Shapiro$28,453,086
- Russ B Hauser$29,562,644
Others in their field
Top investigators on “Transmission Process”
- Lawrence Corey · Fred Hutchinson Cancer Center$395,692,425
- Barton F Haynes · Duke University$361,523,708
- Myron S Cohen · Family Health International$234,988,190
- Wafaa M. El-Sadr · Columbia University Health Sciences$228,712,583
- Richard Webby · St. Jude Children'S Research Hospital$182,265,847
- Barbara Driver · Westat, Inc.$169,952,152
Research focus
Transmission ProcessViralProgramsSuccessSiteSamplingCountryHiv-1PrevalencePharmaceutical PreparationsResistanceGenotypeAnti-Retroviral AgentsResourcesAntiretroviral TherapyCd4 Lymphocyte CountEpidemicGovernmentAdultHiv Drug ResistanceMutationPatternBotswanaVirus
Grant awards (10)
Novel Strategy for HIV Drug Resistance Monitoring in Developing Countries.$320,061
R01 · FY2014 · AI · contact PI
Novel Strategy for HIV Drug Resistance Monitoring in Developing Countries.$300,857
R01 · FY2013 · AI · contact PI
Novel Strategy for HIV Drug Resistance Monitoring in Developing Countries.$320,061
R01 · FY2012 · AI · contact PI
Novel Strategy for HIV Drug Resistance Monitoring in Developing Countries.$308,014
R01 · FY2011 · AI · contact PI
Novel monitoring strategy and fitness analysis of transmitted HIV drug resistance$256,785
R56 · FY2010 · AI · contact PI
Nevirapine Resistance in Women who Received Nevirapine for PMTCT HIV$112,725
K08 · FY2009 · AI · contact PI
Nevirapine Resistance in Women who Received Nevirapine for PMTCT HIV$112,725
K08 · FY2008 · AI · contact PI
Nevirapine Resistance in Women who Received Nevirapine for PMTCT HIV$112,725
K08 · FY2007 · AI · contact PI
Nevirapine Resistance in Women who Received Nevirapine for PMTCT HIV$101,925
K08 · FY2006 · AI · contact PI
Nevirapine Resistance in Women who Received Nevirapine for PMTCT HIV$101,925
K08 · FY2005 · AI